BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
 

GM crops benefit small farmers in Spain - commercially grown Bt maize poses no problem to food and feed chain

Brussels, 27th September 2002 In a new study[1] presented in Brussels today, Brookes West consultancy reports that small farmers in North East Spain are achieving environmental benefits as well as higher yields, better quality and increased income by growing genetically modified maize (Bt Maize). Bt Maize protects the crop against attack by the European Corn Borer (ECB), which can lead to yield losses of 15% or more.

Spanish farmers as well as other Southern European farmers have suffered from the ECB for generations. But currently Spain is the only country in the European Union where GM crops are grown commercially and is therefore the best European example of the benefits Bt Maize offers.

Most Spanish farmers do not use any active form of treatment for dealing with the pest. This is mainly because the larval damage is hidden, heavy infestations are unpredictable, checking the fields multiple times each summer takes time and skill, the difficulty of timing spraying and the perceived high costs of the treatment. Genetically modified insect resistant maize provides a new management tool for all corn producers to increase yields where ECB is a problem.

The average farm size in North East Spain is just 50 hectares, with maize only being grown on part of the area. On average, these small scale farmers received an increased income of €150 (per hectare) compared with growing conventional maize. Their enthusiastic uptake of the GM maize confirms that the benefits of this technology are not limited to large farmlands, in fact delivering pest control can benefit all scales of farming.

Graham Brookes, author of the report, said “Many people don’t realise that GM crops are being successfully grown in the EU. In this North Eastern region of Spain, over 20,000 hectares of Bt maize has been grown every year since 1998”. This represents over 4% of the total Spanish maize crop, and it is estimated that this would rise to 36% if the Bt trait would be freely available in all major maize varieties.

DOWNLOAD THE FULL REPORT (250k IN PDF)

For further information:

Graham Brookes

Brookes West consultancy

Tel: +44 1303 840958                           

email: graham.brookes@btinternet.com   

Adeline Farrelly

EuropaBio Communications Manager

Tel: +32 2 739 1174 (Direct)

Mobile: +32 475 93 17 24

e-mail: a.farrelly@europabio.org

website: http://www.europabio.org

EuropaBio has almost 40 corporate members operating worldwide and 19 national biotechnology associations representing some 1200 SMEs involved in research and development, testing, manufacturing and distribution of biotechnology products. EuropaBio, the voice of European bioindustries, aims to be a promoting force for biotechnology and to present its proposals to industry, politicians, regulators, NGOs, and the public at large.


[1] The research funding for this study came from Agricultural Biotechnology in Europe (ABE) (www.ABEurope.info). 

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.